Hi all
I've been on Imatinib since Jan 24. every set of quarterly blood results since starting has shown a downward trend until now. So
2.5%(apr 24)
0.25% (jul 24
0.1% (oct 24)
0.033% (jan 25)
0.011% (apr 25)
and most recent 0.012% (july 25)
As my response since starting the treatment had been good i have been positive about things and was just expecting it to keep falling to get below 0.01 and into MR4. The nurse who gave me my results said that i would be monitored and if the BCR ABL goes up then the hematologist may switch me to another drug. This is not something i have been wanting to think about as i suppose that would mean the CML has become resistant to imatinib and it rules it out longer term. I have been doing some research and found an article stating if the BCR ABL remains above 0.01% then that is designated as only being a "sub-optimal" response to the meds.
Has anyone else had a similar experience where their BCR-ABL has been falling and then hit a plateau and how did it play out after that? I appreciate that everyone's situation is different but interested to hear people's experiences
Also i am considering going private with BUPA. when i was diagnosed with CML i was told by the hemotologist that whether NHS or private Imatinib is the first TKI but then after that if there is a need to change treatment then there are differences with the private treatment pathway in the uk compared to the NHS. He implied that NHS will follow a fixed route whereas there is more flexibility with which treatment is used next on the private route.
Any advice would be appreciated
thanks
Joey